Skip to main content

Table 3 Prevalence (%) of comorbid conditions in COPD patients from commercial and Medicare data sets*

From: Identifying and characterizing COPD patients in US managed care. A retrospective, cross-sectional analysis of administrative claims data

 

Commercial dataset

(n = 42,565)

Medicare dataset

(n = 8,507)

Respiratory, %

  

   Asthma

27.1

21.3

   Sinusitis

21.2

8.4

   Current tobacco use

19.0

7.5

   Pneumonia

18.8

26.3

   Allergic rhinitis

12.9

6.8

   Sleep apnea

12.5

5.9

   Respiratory failure

8.0

13.0

   Pleurisy/pleural effusion

7.5

11.6

   Pulmonary edema

5.7

11.2

   Pulmonary heart disease

4.2

7.0

   Respiratory tract cancer

4.2

7.1

Non-respiratory, %

  

   Hypertension

55.2

71.6

   Dyslipidemia

48.2

47.3

   Ischemic heart disease/angina

26.5

44.7

   Diabetes

21.9

28.8

   Heart rhythm conduction disturbance

20.4

38.9

   Depression

14.5

9.4

   Heart failure

14.4

33.8

   Kidney disease/abnormal kidney function

11.5

21.9

   Obesity

8.2

4.8

   Cerebrovascular disease

9.2

20.5

   Osteoporosis/decreased bone density

5.7

11.7

   Myocardial Infarction (new or history)

4.1

7.1

  1. *All of the differences comparing prevalence of comorbid conditions between commercial and Medicare populations were significant (p < 0.01), using two-tailed, chi-squared analysis, except for those indicated by italic text.